3,5-Dimethyl-4-[(E)-(2-nitrophenyl)diazenyl]-1-(2,3,4,5,6-pentafluorophenyl)-1H-pyrazole

scientific article published on 18 December 2012

3,5-Dimethyl-4-[(E)-(2-nitrophenyl)diazenyl]-1-(2,3,4,5,6-pentafluorophenyl)-1H-pyrazole is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1107/S0108270112048573
P8608Fatcat IDrelease_w7m44qxa6jfh5p7xpro5btwswe
P698PubMed publication ID23282925

P2093author name stringMaria Teresa Garland
Ricardo Baggio
Carlos Bustos
Fernando Diaz-Marín
Luis Alvarez Thon
P2860cites workA short history of SHELXQ25938995
The Cambridge Structural Database: a quarter of a million crystal structures and risingQ29039683
Structure validation in chemical crystallographyQ30485654
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug designQ31145317
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).Q34424619
Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunctionQ56067856
Fluorine–Fluorine Interactions in the Solid State: An Experimental and Theoretical StudyQ58486660
P433issuePt 1
P304page(s)101-104
P577publication date2012-12-18
P1433published inActa Crystallographica Section C: Crystal Structure CommunicationsQ15708687
P1476title3,5-Dimethyl-4-[(E)-(2-nitrophenyl)diazenyl]-1-(2,3,4,5,6-pentafluorophenyl)-1H-pyrazole
P478volume69